Biocon Ltd. — Capital/Financing Update 2025

Apr 10, 2025

Biocon Limited

20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

BIO/SECL/TG/2025-26/07

April 10, 2025

To,	To,
The Secretary	The Secretary
BSE Limited	National Stock Exchange of India Limited
Department of Corporate Services	Corporate Communication Department
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai – 400 001	Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - BIOCON

Dear Sir/ Madam,

Subject: Certificate pursuant to SEBI Master Circular no. SEBI/HO/DDHS/PoD1/P/CIR/2024/54 dated May 22, 2024.

In terms of Chapter XVII of the SEBI Master Circular no. SEBI/HO/DDHS/PoD1/P/CIR/2024/54 dated May 22, 2024, for issue and listing of Non-convertible Securities, Securitised Debt Instruments, Security Receipts, Municipal Debt Securities and Commercial Paper, please find enclosed a quarterly certificate certifying the use of proceeds of Commercial Paper and adherence to other listing conditions, for the quarter ended March 31, 2025.

We request you to take this on record.

Thanking You.

Yours faithfully,

For Biocon Limited

__________________________ MAYANK VERMA Digitally signed by MAYANK VERMA Date: 2025.04.10 17:41:11 +05'30'

Mayank Verma Company Secretary and Compliance Officer Membership No.: ACS 18776

Encl: As above

Biocon Limited

20th KM Hosur Road Electronic; City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : Ll4234KA 1978PLC003417

To,	To, www.biocon.com
The Secretary	The Secretary
BSE Limited	National Stock Exchange of India Limited
Department of Corporate Services	Corporate Communication Department
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Sandra Kurla Complex
Dalal Street, Mumbai - 400 001	Mumbai - 400 050
Scrip Code - 532523	Scrip Symbol - Biocon

REF NO: ISIN CODE: As Per Annexure I

Maturity Value of CP: As Per Annexure I

Maturity Date of CP: As Per Annexure I

With reference to the above-mentioned Commercial Paper (CP) issued by Biocon Limited (the company), it is hereby certified that:

• 1. The CPs were issued for the purposes mentioned in Annexure I and the CP proceeds were utilized for purposes disclosed therein and the Company is in adherence to other listing conditions as mentioned in the application for listing.
• 1. The other conditions of the offer document and the CP issuance directions are adhered to.
• 1. The asset classification of fund-based facilities from bank/Financial Institutions continues to be "Standard"
• 1. There has been no material change in our financial status which may adversely affect the credit rating of the CP.
• 1. The total issuance of CPs during the calendar year up to the quarter ended Mar 2025 was Rs. 570 Crores.

For Biocon Limited

(Interim Chief Financial Officer)

Date: 10th April 2025 Place: - Bangalore

Annexure I

Issuer Name	of Date CP issue/allotment	ISIN No.	Maturity Value in Rs. Cr	Maturity Date of CP	Units	End Use of Fund
Biocon Limited	29/01/2025	INE376G14024	570	29/04/2025	11400	Acquisition of Equity in a subsidiary